Stay updated with breaking news from Linker mm1 study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Linvoseltamab elicited responses with acceptable safety in patients with relapsed/refractory multiple myeloma, including difficult-to-treat subsets ....